Not independent
Tenure on this board
3.7 yrs
Meeting calendar
RXO · Annual meeting · Tuesday, May 12, 2026
Rxo Inc
8 nominees · 4 ballot items.
Election of eight directors; ratification of Deloitte & Touche LLP as independent registered public accounting firm; approval of an amendment to the RXO, Inc. 2022 Omnibus Incentive Compensation Plan to increase the number of available shares; and advisory vote to approve executive compensation; and other business as may properly come before the annual meeting.
Market cap
$4.8B
1Y TSR
+61.3%
Board grade
C
Record date
Mar 16, 2026
Filing
DEF 14A
Meeting concluded · May 12, 2026
Follow how the vote landed and what changed on Rxo Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Directors
ManagementBoard: FORTo elect eight members of RXO, Inc. Board of Directors for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified.
- 2
Ratification of the Appointment of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm for Fiscal Year 2026
ManagementBoard: FORTo ratify the appointment of Deloitte & Touche LLP as RXO, Inc.’s independent registered public accounting firm for fiscal year 2026.
- 3
Approval of an Amendment to the RXO, Inc. 2022 Omnibus Incentive Compensation Plan to Increase the Number of Available Shares Thereunder
ManagementBoard: FORTo approve an amendment to increase the number of shares of RXO, Inc. common stock available for issuance under the 2022 Omnibus Incentive Compensation Plan by 7,000,000 shares.
- 4
Advisory Vote to Approve Executive Compensation
ManagementBoard: FORTo conduct an advisory vote to approve the executive compensation of RXO, Inc.’s named executive officers (NEOs) as disclosed in the Proxy Statement for the 2026 Annual Meeting.
Director elections
Nominees on the ballot8
Independent
Tenure on this board
3.7 yrs
Also a director at
Sylvamo Corp (SLVM)Mplx LP (MPLX)
Independent
Tenure on this board
2.1 yrs
Independent
Tenure on this board
3.7 yrs
Independent
Tenure on this board
3.7 yrs
Also a director at
Qxo Inc (QXO)Cadre Holdings Inc (CDRE)
Independent
Tenure on this board
3.7 yrs
Independent
Tenure on this board
3.7 yrs
Independent
Tenure on this board
3.7 yrs
Also a director at
Seagate Technology Holdings PLC (STX)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Orbis Allan Gray Ltd | 21.0% | 34,686,304 | $507M |
| 2 | MFN Partners Management, LP | 17.0% | 28,109,942 | $411M |
| 3 | BlackRock, Inc. | 10.6% | 17,561,681 | $257M |
| 4 | Finepoint Capital LP | 6.1% | 10,073,618 | $147M |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 9,034,799 | $132M |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 7,370,484 | $108M |
| 7 | STATE STREET CORP | 4.0% | 6,568,340 | $96M |
| 8 | FIL Ltd | 4.0% | 6,550,000 | $96M |
| 9 | BlackRock, Inc. | 2.9% | 4,829,264 | $71M |
| 10 | Hood River Capital Management LLC | 2.7% | 4,452,216 | $65M |
Peers
Nearest market capOther Industrials sector meetings6
Upcoming shareholder meetings at Rxo Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Csw Industrials IncCSW
Annual meeting·Aug 27, 2026·$4.6B
EnersysENS
Annual meeting·Aug 6, 2026·$7.2B
Booz Allen Hamilton Holding CorpBAH
Annual meeting·Jul 22, 2026·$7.8B
American Superconductor CorpAMSC
Annual meeting·Jul 31, 2026·$1.6B
Graham CorpGHM
Annual meeting·Aug 25, 2026·$1.3B
Power Solutions International IncPSIX
Annual meeting·Jul 23, 2026·$697M
Reference
Frequently asked questions
- When is the Rxo Inc 2026 annual meeting?
- Rxo Inc (RXO) holds its 2026 annual shareholder meeting on Tuesday, May 12, 2026.
- What is the record date for the Rxo Inc 2026 meeting?
- The record date for the Rxo Inc 2026 meeting is Monday, March 16, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Rxo Inc's 2026 meeting?
- The board is presenting 8 director nominees at the Rxo Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Rxo Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Rxo Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.